Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT

Avichai Shimoni, Marie Robin, Simona Iacobelli, Dietrich Beelen, Ghulam J. Mufti, Fabio Ciceri, Wolfgang Bethge, Liisa Volin, Didier Blaise, Arnold Ganser, Thomas Luft, Patrice Chevallier, Rainer Schwerdtfeger, Linda Koster, Theo de Witte, Nicolaus Kroeger, Arnon Nagler, Ibrahim Yakoub-Agha

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalBritish Journal of Haematology
Volume195
Issue number3
Pages (from-to)417-428
Number of pages12
ISSN0007-1048
DOIs
Publication statusPublished - Nov 2021
MoE publication typeA1 Journal article-refereed

Fields of Science

  • myelodysplastic syndrome
  • allogeneic haematopoietic cell transplantation
  • reduced-intensity conditioning
  • myeloablative conditioning
  • treosulfan
  • ACUTE MYELOID-LEUKEMIA
  • VERSUS-HOST-DISEASE
  • PREPARATIVE REGIMEN
  • OPEN-LABEL
  • FLUDARABINE
  • MARROW
  • TOXICITY
  • BUSULFAN
  • GRAFT
  • MDS
  • 3122 Cancers

Cite this